BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Adipose tissue
,
Neocentromeres
,
Doxorubicin
,
rs4950928
,
VEGFA
,
Apoptosis
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
c Maf
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
MAFB+ cells from c-MAF knockout embryonic gonads
Whole kidneys from mice with tamoxifen-induced c-Maf-knockout
Dorsal root ganglia of 15d old mice with C-MAF conditional gene knockout
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
Multipotent mesenchymal stromal cells: TGFβ3/BMP2 induced chondrogenesis
Explore Curated Studies Results
Literature
Most Relevant Literature
Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis.
In vitro generation of platelets through direct conversion: first report in My Knowledge (iMK).
Tyrosine phosphorylation of c-Maf enhances the expression of IL-4 gene.
V. Molecular classification and risk stratification of myeloma.
c-Maf expression in angioimmunoblastic T-cell lymphoma reflects follicular helper T-cell derivation …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of MAF-1217 in Patients With DED
Trial Efficacy of Saisei Pharma Dietary Supplements MAF Capsules, 148 mg and M Capsules, 148 mg in H…
Efficacy and Safety of Oral Immunotherapy With GcMAF in Hospitalized Patients With COVID-19 Pneumoni…
Effect of Periodontal Therapy on Biomarkers in Periodontitis
2006-32 Phase II Study of Rapidly Recycled High Dose DTPACE
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ